News
-
-
-
PRESS RELEASE
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases -
PRESS RELEASE
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results -
PRESS RELEASE
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
Zomedica Corp. to host a conference call on August 14, 2024, at 4:30 p.m. ET to discuss Q2 2024 financial results. The company provides veterinary health products for animals -
PRESS RELEASE
"NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market" - Conclude Two Independent Research Reports on NanoViricides
NanoViricides, Inc., reports on independent research highlighting NV-387's broad-spectrum action in viral therapy, potentially revolutionizing antiviral treatment strategies -
-
PRESS RELEASE
SUN.io Launches SUN DAO to Enhance Decentralized Governance and Drive Ecosystem Innovation
SUN.io launches SUN DAO, a decentralized governance initiative on TRON blockchain, enhancing community autonomy and protocol governance. SUN DAO to revolutionize DeFi governance, incentivizing active participation and innovation -
-